However, the year-on-year increasing amount of data and the incoherencies of some of the results indicate that the molecular role of RBMS3, especially in the regulation of cancer development, is a good subject for further research that may lead to the development of novel diagnostic and therapeutic strategies that will improve the outcome of patients with neoplastic diseases. This evidence concerns the gene RBMS3 and cancer.